Latest News

Researchers found that former NFL players had a 3.8-fold higher mortality rate for all-cause dementia and a nearly 3.9-fold higher mortality rate for Parkinson’s disease, according to a study involving over 19,800 former NFL players.

The Alturion ultrasound device reportedly combines portability, AI-enhanced capabilities and a user-friendly interface to facilitate streamlined workflows.

Deep learning-based motion correction with the CLEAR Motion software reportedly bolsters cardiac imaging quality while the PIQE 1024 Deep Learning Reconstruction software offers equivalent SNR to photon-counting CT for high-resolution views of objects less than 0.5 mm.

Researchers said the combination of 18F-flotufolastat PET/MRI may lead to a 57 percent reduction of prostate biopsies in comparison to a 25 percent reduction with prostate MRI alone.

The newly FDA-cleared PACS Viewer from CliniComp reportedly allows direct review and analysis of imaging within a patient’s chart.

In a recent interview, Nina Kottler, MD, offered her perspective on findings from a recent report on AI in health care, AI integration challenges and what the future holds with AI in radiology.

In comparison to everolimus, the peptide receptor radionuclide therapy (177Lu)Lu-edotreotide provided over a nine month longer median progression-free survival for patients with gastroenteropancreatic neuroendocrine tumours (GEP NETs), according to new phase 3 research.

In an amusing take on the subject, this author suggests that having a colleague with dedicated expertise in curtailing unnecessary imaging requests could have an impact in reducing burgeoning worklists.

Catch up on the top radiology content of the past week.

In a recent interview, Amy Patel, MD, discussed recent research on breast cancer screening, pertinent obstacles and keys to facilitating improved adherence with mammography screening.

While acknowledging key limitations, the authors of a new literature review noted that contrast-enhanced mammography offers a viable alternative to conventional imaging and breast MRI for preoperative tumor evaluation and may have a significant impact on surgical management.

Emerging research demonstrates that those with total plaque volume > 750 mm3 have an 18.6 percent risk of MACE at four years in comparison to a 1.4 percent MACE risk for those with no plaque.

The Star RF Electrode and VIVA RF Electrode are reportedly the first devices to garner a specific cleared indication for benign thyroid nodule ablation.